{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:18:35Z","timestamp":1794745115930,"version":"4.9.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020405","name":"Holy House of Mercy of Lisbon","doi-asserted-by":"publisher","award":["MB-28-2019"],"award-info":[{"award-number":["MB-28-2019"]}],"id":[{"id":"10.13039\/501100020405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["2021.00643.CEECIND"],"award-info":[{"award-number":["2021.00643.CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119954","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:58:03Z","timestamp":1790614683000},"page":"119954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in the management of depression in Parkinson\u2019s disease: A narrative review on vortioxetine, hyperbaric oxygen, and physical activity"],"prefix":"10.1016","volume":"204","author":[{"given":"Irene","family":"Mesquita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-7821","authenticated-orcid":false,"given":"Carla","family":"Soares-Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-7641","authenticated-orcid":false,"given":"Catarina","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-6359","authenticated-orcid":false,"given":"Rita","family":"Caridade-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Summavielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-0446","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Godinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio G.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119954_bib1","first-page":"S3","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018"},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119954_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"16","key":"10.1016\/j.biopha.2026.119954_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1212\/WNL.0000000000009285","article-title":"A call for better depression treatment in people with Parkinson disease","volume":"94","author":"Pontone","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119954_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","article-title":"Association between depression and the subsequent risk of Parkinson\u2019s disease: A meta-analysis","volume":"86","author":"Wang","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.biopha.2026.119954_bib7","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10072-023-06740-w","article-title":"Exploring depression in Parkinson\u2019s disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management","volume":"44","author":"Stocchi","year":"2023","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/brainsci13020318","article-title":"Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders","volume":"13","author":"Pagonabarraga","year":"2023","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","article-title":"The impact of depressive symptoms in early Parkinson disease","volume":"69","author":"Ravina","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","article-title":"Advances in the treatment of Parkinson\u2019s disease","volume":"81","author":"Singh","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737175.2023.2177535","article-title":"How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson\u2019s disease?","volume":"23","author":"Lenka","year":"2023","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14802\/jmd.25008","article-title":"Drug Repositioning and Repurposing for Disease-Modifying Effects in Parkinson\u2019s Disease","volume":"18","author":"Jeong","year":"2025","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119954_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2018.09.011","article-title":"The importance of preclinical diagnostics in Parkinson disease","volume":"64","author":"Mantri","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"47","key":"10.1016\/j.biopha.2026.119954_bib14","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric Manifestation in Patients with Parkinson\u2019s Disease","volume":"33","author":"Han","year":"2018","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119954_bib15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/medicina59081454","article-title":"Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson\u2019s Disease: An Updated Review","volume":"59","author":"Angelopoulou","year":"2023","journal-title":"Medicina"},{"issue":"s1","key":"10.1016\/j.biopha.2026.119954_bib16","first-page":"S135","article-title":"Non-Pharmacological Interventions for Depression and Anxiety in Parkinson\u2019s Disease","volume":"14","author":"Van Wegen","year":"2024","journal-title":"J. Park. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2026.119954_bib17","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib18","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s10072-025-07987-1","article-title":"Use of vortioxetine in different neurological fields: a systematic review and future perspectives","volume":"46","author":"Verrienti","year":"2025","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1092852915000139","article-title":"Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors)","volume":"20","author":"Stahl","year":"2015","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1192\/bja.2022.14","article-title":"Recent advances in the psychopharmacology of major depressive disorder","volume":"29","author":"Alexander","year":"2023","journal-title":"BJPsych Adv."},{"key":"10.1016\/j.biopha.2026.119954_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ijnp\/pyad018","article-title":"Effectiveness and Safety of Vortioxetine for the Treatment of Major Depressive Disorder in the Real World: A Systematic Review and Meta-Analysis","volume":"26","author":"Li","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.drudis.2018.01.033","article-title":"Safinamide: a new hope for Parkinson\u2019s disease?","volume":"23","author":"Teixeira","year":"2018","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.biopha.2026.119954_bib24","article-title":"de","volume":"26","author":"Mohammad Jafari","year":"2018","journal-title":"Drug. Repositioning A Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119954_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108977","article-title":"Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson\u2019s disease via targeting TLR-2 mediated neuroinflammation","volume":"208","author":"Nemutlu Samur","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119954_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176929","article-title":"Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K\/Akt\/CREB\/BDNF cascade and modulation of serotonergic pathway signaling","volume":"982","author":"Shafiek","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119954_bib28","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.3390\/ijms22179608","article-title":"Novel Approaches Used to Examine and Control Neurogenesis in Parkinson\u2032s Disease","volume":"22","author":"Salmina","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib29","first-page":"1345","article-title":"The Human Hippocampus in Parkinson\u2019s Disease: An Integrative Stereological and Proteomic Study","volume":"11","author":"Villar-Conde","year":"2021","journal-title":"J. Park. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2026.119954_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/17425255.2025.2566692","article-title":"Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders","volume":"21","author":"Alborghetti","year":"2025","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib31","article-title":"Drug interactions with vortioxetine, a new multimodal antidepressant","volume":"50","author":"Spina","year":"2015","journal-title":"Riv. Psichiatr."},{"key":"10.1016\/j.biopha.2026.119954_bib32","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X361647250416072053","article-title":"Vortioxetine for the Treatment of Depression in Patients with Parkinson\u2019s Disease: A 16-week Pilot, Prospective, Open-label Safety Study","volume":"23","author":"Stocchi","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2026.119954_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2013.01.019","article-title":"Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats","volume":"105","author":"M\u00f8rk","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","article-title":"Psychosis, apathy, depression and anxiety in Parkinson\u2019s disease","volume":"46","author":"Gallagher","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119954_bib35","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.toxrep.2021.11.003","article-title":"Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report","volume":"8","author":"Thumtecho","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.biopha.2026.119954_bib36","first-page":"1","article-title":"Vortioxetine for the treatment of depressive episodes associated with Parkinson\u2019s disease: a case series of six patients","author":"Barbato","year":"2020","journal-title":"J. Psychopathol."},{"key":"10.1016\/j.biopha.2026.119954_bib37","volume":"34","author":"Russo","year":"2019"},{"issue":"11","key":"10.1016\/j.biopha.2026.119954_bib38","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/brainsci12111466","article-title":"Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson\u2019s Disease Patients with Major Depression: An Open-Label Prospective Study","volume":"12","author":"Santos Garc\u00eda","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2026.119954_bib39","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.15750","article-title":"Vortioxetine Improved Depressive State In Parkinson\u2019s Disease","author":"Yoshimura","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14412\/2074-2711-2020-5-40-45","article-title":"The use of vortioxetine for depression in patients with Parkinson\u2019s disease in the early and advanced stages of the disease","volume":"12","author":"Miliukhina","year":"2020","journal-title":"Neurol. Neuropsychiatry Psychosom."},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0000000000000911","article-title":"Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study","volume":"38","author":"Guo","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12888-020-02711-z","article-title":"Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database","volume":"20","author":"Revet","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/cells12060837","article-title":"Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia","volume":"12","author":"Budrow","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119954_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2026.1761550","article-title":"Comparative effect of vortioxetine and sertraline on clinical and inflammatory profile in Parkinson\u2019s disease with comorbid depression","volume":"20","author":"Alborghetti","year":"2026","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","article-title":"The heterogeneity of Parkinson\u2019s disease","volume":"130","author":"W\u00fcllner","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2026.119954_bib47","series-title":"Hyperbaric oxygen therapy indications","year":"2019"},{"issue":"25","key":"10.1016\/j.biopha.2026.119954_bib48","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM199606203342506","article-title":"Hyperbaric-Oxygen Therapy","volume":"334","author":"Tibbles","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119954_bib49","unstructured":"Jones M.W., Brett K., Han N., Cooper J.S., Wyatt H.A. Hyperbaric Physics. Em: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [citado 8 de janeiro de 2026]. Dispon\u00edvel em: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448104\/ PubMed PMID: 28846268."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yasu.2022.02.011","article-title":"Is There a Place for Hyperbaric Oxygen Therapy?","volume":"56","author":"Sethuraman","year":"2022","journal-title":"Adv. Surg. setembro De."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib51","first-page":"176","article-title":"Essentials of Hyperbaric Oxygen Therapy: 2019 Review","volume":"116","author":"Kirby","year":"2019","journal-title":"Mo Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2045-9912.310057","article-title":"Therapeutic effects of hyperbaric oxygen: integrated review","volume":"11","author":"Sen","year":"2021","journal-title":"Med. Gas. Res. Jan. De."},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/CH-209222","article-title":"Effect of HBO therapy on adipose-derived stem cells, fibroblasts and co-cultures: In vitro study of oxidative stress, angiogenic potential and production of pro-inflammatory growth factors in co-cultures1","volume":"76","author":"Engel","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"9","key":"10.1016\/j.biopha.2026.119954_bib54","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jfma.2014.03.012","article-title":"Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia","volume":"113","author":"Chen","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib55","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1152\/japplphysiol.91004.2008","article-title":"Oxidative stress is fundamental to hyperbaric oxygen therapy","volume":"106","author":"Thom","year":"2009","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11357-022-00707-z","article-title":"The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases","volume":"45","author":"Mensah-Kane","year":"2023","journal-title":"GeroScience"},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/biom12050661","article-title":"Hyperbaric Oxygen Therapy Improves Parkinson\u2019s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1\/PGC-1\u03b1 Pathway","volume":"12","author":"Hsu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119954_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neures.2017.11.008","article-title":"Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson\u2019s disease","volume":"132","author":"Kusuda","year":"2018","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.biopha.2026.119954_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neulet.2015.06.030","article-title":"Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson\u2019s disease in rats","volume":"600","author":"Pan","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2045-9912.311498","article-title":"A review on the neuroprotective effects of hyperbaric oxygen therapy","volume":"11","author":"Ahmadi","year":"2021","journal-title":"Med. Gas. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib61","doi-asserted-by":"crossref","DOI":"10.5498\/wjp.v16.i3.113572","article-title":"A P. Efficacy of hyperbaric oxygen therapy in the treatment of depression","volume":"16","author":"Ahsan","year":"2026","journal-title":"World J. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98245-9","article-title":"Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial","volume":"11","author":"Bloch","year":"2021","journal-title":"Sci. Rep."},{"issue":"29","key":"10.1016\/j.biopha.2026.119954_bib63","article-title":"Effects of hyperbaric oxygen therapy on depression and anxiety in the patients with incomplete spinal cord injury (a STROBE-compliant article)","volume":"96","author":"Feng","year":"2017","journal-title":"Med. (Baltim. )"},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1589\/jpts.27.1295","article-title":"The effects of combined hyperbaric oxygen therapy on patients with post-stroke depression","volume":"27","author":"Yan","year":"2015","journal-title":"J. Phys. Ther. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib65","doi-asserted-by":"crossref","DOI":"10.25270\/wmp.22094","article-title":"The Effect of Hyperbaric Oxygen Therapy on Psychological State and Wound Healing: A Case Report","volume":"70","author":"Antunes","year":"2024","journal-title":"Wound Manag. Prev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib66","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/pm\/pnaa416","article-title":"Evaluation of a Hyperbaric Oxygen Therapy Intervention in Individuals with Fibromyalgia","volume":"22","author":"Curtis","year":"2021","journal-title":"Pain. Med."},{"key":"10.1016\/j.biopha.2026.119954_bib67","article-title":"Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial","volume":"18","author":"Ablin","year":"2023"},{"key":"10.1016\/j.biopha.2026.119954_bib68","article-title":"Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial","author":"Atzeni","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/neu.2011.1895","article-title":"A Phase I Study of Low-Pressure Hyperbaric Oxygen Therapy for Blast-Induced Post-Concussion Syndrome and Post-Traumatic Stress Disorder","volume":"29","author":"Harch","year":"2012","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2045-9912.279978","article-title":"Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial","volume":"10","author":"Harch","year":"2020","journal-title":"Med. Gas. Res."},{"issue":"9","key":"10.1016\/j.biopha.2026.119954_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010029","article-title":"Hyperbaric oxygen treatment for Parkinson\u2019s disease with severe depression and anxiety: A case report","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2026.119954_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17582024.2026.2665357","article-title":"Neuro-reparative potential of hyperbaric oxygen therapy in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases: systematic review and meta-analysis","author":"Radhakrishnan","year":"2026","journal-title":"Neurodegener. Dis. Manag."},{"issue":"8","key":"10.1016\/j.biopha.2026.119954_bib73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1559827620912192","article-title":"Exercise Is Medicine","volume":"14","author":"Thompson","year":"2020","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.biopha.2026.119954_bib75","unstructured":"2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Wash DC US Dep Health Hum Serv. 2018."},{"issue":"8","key":"10.1016\/j.biopha.2026.119954_bib76","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson\u2019s disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib77","article-title":"Physical exercise for people with Parkinson\u2019s disease: a systematic review and network meta-analysis","volume":"2024","author":"Ernst","year":"2024","journal-title":"Cochrane Mov. Disord. Group. Editor. Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2026.119954_bib78","first-page":"S21","article-title":"The Universal Prescription for Parkinson\u2019s Disease: Exercise","volume":"10","author":"Alberts","year":"2020"},{"issue":"24","key":"10.1016\/j.biopha.2026.119954_bib79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br. J. Sports Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib80","first-page":"311","article-title":"Clinical Trial Highlights \u2013 Interventions Promoting Physical Activity in Parkinson\u2019s Disease","volume":"13","author":"Oosterhof","year":"2023","journal-title":"J. Park. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/NPT.0000000000000507","article-title":"Promoting Physical Activity in People With Parkinson\u2019s Disease Through a Smartphone App: A Pilot Study","volume":"49","author":"Schootemeijer","year":"2025","journal-title":"J. Neurol. Phys. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.31083\/j.jin2105132","article-title":"Physical Activity as a Clinical Tool against Depression: Opportunities and Challenges","volume":"21","author":"Chen","year":"2022","journal-title":"J. Integr. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40120-021-00270-3","article-title":"Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology","volume":"10","author":"Amjad","year":"2021","journal-title":"Neurol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-025-03096-7","article-title":"How to treat cardiovascular autonomic failure in Parkinson\u2019s disease","volume":"133","author":"Fanciulli","year":"2026","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/mds.27268","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: A prospective cohort study","volume":"33","author":"Merola","year":"2018","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41531-021-00222-6","article-title":"Parkinson\u2019s disease patients benefit from bicycling - a systematic review and meta-analysis","volume":"7","author":"Tiihonen","year":"2021","journal-title":"npj Park. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2026.119954_bib87","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/jnnp-2023-332974","article-title":"Exercise as medicine in Parkinson\u2019s disease","volume":"95","author":"Langeskov-Christensen","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119954_bib88","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2019.09.040","article-title":"Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity","volume":"107","author":"Kandola","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2026.119954_bib89","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fneur.2019.01143","article-title":"Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson\u2019s Disease","volume":"10","author":"Palasz","year":"2019","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib90","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/15459683231172752","article-title":"Does Exercise Attenuate Disease Progression in People With Parkinson\u2019s Disease? A Systematic Review With Meta-Analyses","volume":"37","author":"Li","year":"2023","journal-title":"Neurorehabil Neural Repair."},{"key":"10.1016\/j.biopha.2026.119954_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1275924","article-title":"Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction","volume":"16","author":"Cefis","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-024-00641-1","article-title":"Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson\u2019s disease","volume":"10","author":"De Laat","year":"2024","journal-title":"npj Park. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.26291","article-title":"Aerobic Exercise Alters Brain Function and Structure in Parkinson\u2019s Disease: A Randomized Controlled Trial","volume":"91","author":"Johansson","year":"2022","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1545968314542981","article-title":"Intensive Rehabilitation Treatment in Early Parkinson\u2019s Disease: A Randomized Pilot Study With a 2-Year Follow-up","volume":"29","author":"Frazzitta","year":"2015","journal-title":"Neurorehabil Neural Repair."},{"issue":"8","key":"10.1016\/j.biopha.2026.119954_bib95","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000013218","article-title":"Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease","volume":"98","author":"Tsukita","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib96","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s13063-022-06703-0","article-title":"Study in Parkinson\u2019s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial","volume":"23","author":"Patterson","year":"2022","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib97","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamapsychiatry.2022.0609","article-title":"Association Between Physical Activity and Risk of Depression: A Systematic Review and Meta-analysis","volume":"79","author":"Pearce","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopha.2026.119954_bib98","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jad.2021.09.043","article-title":"Efficacy of exercise combined with standard treatment for depression compared to standard treatment alone: A systematic review and meta-analysis of randomized controlled trials","volume":"295","author":"Lee","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"23","key":"10.1016\/j.biopha.2026.119954_bib99","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bjsports-2022-105964","article-title":"Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials","volume":"56","author":"Recchia","year":"2022","journal-title":"Br. J. Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41380-022-01819-w","article-title":"The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes","volume":"28","author":"Ross","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2026.119954_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/inm.70054","article-title":"The Effects of Aerobic and Resistance Exercise on Depression and Anxiety: Systematic Review With Meta-Analysis","volume":"34","author":"Banyard","year":"2025","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.biopha.2026.119954_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075847","article-title":"Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials","volume":"384","author":"Noetel","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41531-025-01113-w","article-title":"New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson\u2019s disease","volume":"11","author":"Chen","year":"2025","journal-title":"npj Park. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib104","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1076167502250792","article-title":"Physical Activity as a Nonpharmacological Treatment for Depression: A Review","volume":"8","author":"Phillips","year":"2003","journal-title":"Complement. Health Pract. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/brainsci15040357","article-title":"Dance Well\u201d\u2014A Multisensory Artistic Dance Intervention for People with Parkinson\u2019s Disease: A Pilot Study","volume":"15","author":"Volpe","year":"2025","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib106","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/08919887241237223","article-title":"Physical Exercise for Treating the Anxiety and Depression Symptoms of Parkinson\u2019s Disease: Systematic Review and Meta-Analysis","volume":"37","author":"Costa","year":"2024","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib107","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.apmr.2022.07.021","article-title":"Exercise for Depressive Symptoms in Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"104","author":"Feller","year":"2023","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.biopha.2026.119954_bib108","article-title":"meng. Effects of exercise modalities on cognitive function and depression in patients with Parkinson\u2019s disease: A systematic review and network meta-analysis","volume":"66","author":"Yan","year":"2025","journal-title":"Geriatr. Nur."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/BPL-180069","article-title":"The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging","volume":"4","author":"Vecchio","year":"2018","journal-title":"Brain Plast."},{"key":"10.1016\/j.biopha.2026.119954_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1502417","article-title":"Physical activity and neuroplasticity in neurodegenerative disorders: a comprehensive review of exercise interventions, cognitive training, and AI applications","volume":"19","author":"Ben Ezzdine","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2026.119954_bib111","series-title":"Physical Therapy and Rehabilitation - Research and Clinical Application [Internet]","article-title":"Exercise Therapies and Their Neurophysiological Basis","author":"Gul","year":"2025"},{"issue":"17","key":"10.1016\/j.biopha.2026.119954_bib112","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.3390\/ijms26178697","article-title":"Adaptations in Mitochondrial Function Induced by Exercise: A Therapeutic Route for Treatment-Resistant Depression","volume":"26","author":"Ramos-Jim\u00e9nez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.biopha.2026.119954_bib113","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/cells13231940","article-title":"Impact of Physical Activity on Cellular Metabolism Across Both Neurodegenerative and General Neurological Conditions: A Narrative Review","volume":"13","author":"Clemente-Su\u00e1rez","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119954_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107913","article-title":"Exercise and the organ-brain axis: Regulation of neurological disorders by emerging exerkines","volume":"219","author":"Dai","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119954_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13102-025-01119-0","article-title":"Impact of resistance and high-intensity interval training on body composition, physical function, and temporal dynamics of adaptation in older women with impaired cardiometabolic health: a randomized clinical trial","volume":"17","author":"Cano-Montoya","year":"2025","journal-title":"BMC Sports Sci. Med. Rehabil."},{"issue":"03","key":"10.1016\/j.biopha.2026.119954_bib116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/a-1551-9294","article-title":"The Molecular Signature of High-intensity Training in the Human","volume":"43","author":"Wahl","year":"2022","journal-title":"Body. Int. J. Sports Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119954_bib117","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.28379","article-title":"Seven Solutions for Neuroprotection in Parkinson\u2019s Disease","volume":"36","author":"Devos","year":"2021","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2026.119954_bib118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/biomedicines14051130","article-title":"From Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson\u2019s Disease","volume":"14","author":"Kazanskaya","year":"2026","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.biopha.2026.119954_bib119","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/ph14060595","article-title":"Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review","volume":"14","author":"Krzystanek","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.biopha.2026.119954_bib120","doi-asserted-by":"crossref","DOI":"10.12669\/pjms.37.4.3993","article-title":"Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function","volume":"37","author":"Mi","year":"2021","journal-title":"Pak. J. Med. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600990X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600990X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:57:00Z","timestamp":1794743820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600990X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":120,"alternative-id":["S075333222600990X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119954","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the management of depression in Parkinson\u2019s disease: A narrative review on vortioxetine, hyperbaric oxygen, and physical activity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119954"}}